KMCSHIL

K M C Speciality Hospitals (India) Limited

K M C Speciality Hospitals (India) Limited (KMCSHIL) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Hospital

kauveryhospital.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹161.69
Market cap
2,637 Cr
Stock P/E
47.3
P/B
12.53
ROE (FY26)
22.2%
ROCE (FY26)
25.3%
Operating margin (FY26)
21.7%
Debt / equity (FY26)
0.34
OCF / EBITDA (FY26)
90.0%
OCF / EBITDA (3Y)
91.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

Company snapshot

18thBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives
  • ✓Net margin of 15.3% — the business keeps a healthy share of every rupee it earns.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales42 Cr49 Cr45 Cr53 Cr56 Cr61 Cr61 Cr67 Cr75 Cr82 Cr82 Cr92 Cr
Operating expenses (approx.)31 Cr35 Cr33 Cr40 Cr44 Cr45 Cr46 Cr50 Cr54 Cr57 Cr56 Cr63 Cr
EBITDA11 Cr14 Cr12 Cr13 Cr13 Cr16 Cr15 Cr16 Cr21 Cr25 Cr26 Cr28 Cr
OPM %26.3%29.3%26.3%24.4%22.3%26.1%25.3%24.7%27.8%30.2%31.5%31.0%
Other income0.57 Cr0.58 Cr0.77 Cr0.62 Cr0.46 Cr1 Cr0.79 Cr0.80 Cr1 Cr1 Cr2 Cr2 Cr
Interest0.21 Cr0.24 Cr0.50 Cr2 Cr3 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Depreciation2 Cr2 Cr3 Cr4 Cr5 Cr5 Cr5 Cr5 Cr5 Cr5 Cr6 Cr6 Cr
Profit before tax9 Cr12 Cr9 Cr7 Cr5 Cr10 Cr9 Cr10 Cr15 Cr18 Cr20 Cr22 Cr
Tax %26.0%24.0%24.8%25.5%27.2%25.2%48.7%24.7%26.4%25.7%26.1%26.1%
Net profit7 Cr9 Cr7 Cr6 Cr4 Cr8 Cr5 Cr8 Cr11 Cr14 Cr15 Cr17 Cr
EPS (₹)₹0.42₹0.58₹0.43₹0.34₹0.24₹0.46₹0.27₹0.46₹0.66₹0.84₹0.90₹1.02

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales55 Cr71 Cr82 Cr96 Cr103 Cr136 Cr156 Cr177 Cr232 Cr306 CrSign in free for the trailing twelve months
Operating expenses (approx.)43 Cr57 Cr66 Cr75 Cr79 Cr99 Cr114 Cr130 Cr175 Cr218 CrSign in free for the trailing twelve months
EBITDA12 Cr14 Cr16 Cr21 Cr23 Cr37 Cr41 Cr47 Cr57 Cr88 CrSign in free for the trailing twelve months
OPM %22.4%20.0%19.4%21.9%22.6%27.3%26.5%26.7%24.6%28.8%Sign in free for the trailing twelve months
Other income0.12 Cr0.32 Cr2 Cr1 Cr2 Cr2 Cr3 Cr4 Cr3 Cr5 CrSign in free for the trailing twelve months
Interest1 Cr0.79 Cr1 Cr0.86 Cr0.95 Cr0.70 Cr0.81 Cr1 Cr9 Cr8 CrSign in free for the trailing twelve months
Depreciation3 Cr4 Cr4 Cr5 Cr6 Cr7 Cr8 Cr9 Cr19 Cr22 CrSign in free for the trailing twelve months
Profit before tax8 Cr10 Cr12 Cr17 Cr18 Cr32 Cr36 Cr41 Cr32 Cr63 CrSign in free for the trailing twelve months
Tax %33.0%32.1%30.2%29.7%29.2%26.1%25.8%25.1%32.2%25.8%Sign in free for the trailing twelve months
Net profit5 Cr7 Cr9 Cr12 Cr13 Cr24 Cr27 Cr30 Cr21 Cr47 CrSign in free for the trailing twelve months
EPS (₹)₹0.33₹0.41₹0.53₹0.72₹0.78₹1.45₹1.64₹1.86₹1.31₹2.87Sign in free for the trailing twelve months
Dividend payout %————0.0%0.0%0.0%0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr
Reserves8 Cr14 Cr23 Cr34 Cr47 Cr70 Cr97 Cr127 Cr148 Cr194 Cr
Borrowings3 Cr11 Cr8 Cr6 Cr28 Cr29 Cr45 Cr72 Cr82 Cr71 Cr
Other liabilities11 Cr11 Cr13 Cr13 Cr14 Cr13 Cr24 Cr48 Cr40 Cr51 Cr
Total liabilities38 Cr53 Cr60 Cr70 Cr105 Cr129 Cr182 Cr264 Cr286 Cr332 Cr
Fixed assets (net)24 Cr36 Cr35 Cr38 Cr73 Cr74 Cr83 Cr205 Cr247 Cr247 Cr
CWIP——0.09 Cr0.07 Cr2 Cr6 Cr34 Cr0.64 Cr0 Cr—
Investments—0.0022 Cr0.41 Cr0.41 Cr0.41 Cr0.41 Cr0.41 Cr0.41 Cr0.41 Cr0.41 Cr
Loans & advances——1.00 Cr1 Cr0.12 Cr0.13 Cr0.18 Cr0.16 Cr0.26 Cr0.29 Cr
Inventories0.68 Cr0.68 Cr0.94 Cr2 Cr2 Cr2 Cr2 Cr2 Cr4 Cr4 Cr
Trade receivables2 Cr2 Cr2 Cr2 Cr3 Cr4 Cr4 Cr4 Cr6 Cr7 Cr
Cash & bank0.87 Cr0.35 Cr2 Cr1 Cr2 Cr2 Cr2 Cr5 Cr9 Cr50 Cr
Other assets11 Cr13 Cr19 Cr25 Cr23 Cr41 Cr55 Cr46 Cr19 Cr23 Cr
Total assets38 Cr53 Cr60 Cr70 Cr105 Cr129 Cr182 Cr264 Cr286 Cr332 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity10 Cr12 Cr16 Cr11 Cr30 Cr29 Cr32 Cr38 Cr58 Cr79 Cr
Cash from investing-4 Cr-19 Cr-9 Cr-8 Cr-47 Cr-29 Cr-48 Cr-56 Cr-51 Cr-17 Cr
Cash from financing-5 Cr6 Cr-5 Cr-4 Cr18 Cr-1 Cr16 Cr20 Cr-2 Cr-21 Cr
Net cash flow0.59 Cr-0.52 Cr1 Cr-0.66 Cr1 Cr-0.46 Cr0.17 Cr3 Cr4 Cr41 Cr
Free cash flow (OCF − Capex)6 Cr-3 Cr13 Cr7 Cr30 Cr29 Cr-12 Cr-37 Cr-6 Cr62 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %33.6%25.4%28.8%30.7%20.8%28.4%23.3%19.3%16.7%25.3%
ROE %22.3%21.9%22.0%23.2%20.2%27.3%23.5%21.2%13.0%22.2%
Debtor days1113889910999
Inventory days17514418055823825628720812996
Days payable83586910141092706738810769517252
Cash conversion cycle-649-713-826-526-460-473-513-552-379-146
OCF / EBITDA %81.7%87.8%99.0%50.7%127.9%78.3%78.2%81.1%101.2%90.0%
OCF / EBITDA % (3 years)——90.3%76.0%93.3%85.3%89.6%79.3%88.1%91.1%
Debt / equity0.140.370.200.130.440.330.390.500.500.34
Current ratio0.410.681.011.432.082.182.370.720.881.90
Net debt / EBITDA0.210.770.370.251.110.731.031.431.280.24